Results 281 to 290 of about 5,235,363 (361)

Radiomics analysis of restaging MRI for detection of pathological complete response in locally advanced rectal cancer. [PDF]

Eur J Radiol Open
Ambrosini I, Francischello R, Fanni SC, Faggioni L, Aringhieri G, Fruzza R, Cwiklinska K, Caputo FP, Aghakhanyan G, Neri E, Lencioni R, Cioni D.   +11 more
europepmc   +1 more source

Combining radiotherapy with CAR‐T cell therapy for solid tumors: Challenges, mechanisms, and future directions

Precision Radiation Oncology, EarlyView.
Radiotherapy enhances CAR‐Tcell therapy by increasing antigenicity, improving trafficking, and reshaping the tumor microenvironment. Despite its dual effects, including potential immune suppression, understanding these mechanisms enables the development of strategies to maximize synergy in solid tumors.
Leran Qiu, Xingyu Zhou, Jiao Xue, Xiaokang Zhang, Songbing Qin   +4 more
wiley   +1 more source

Regarding: "sarcopenia is a bad harbinger of cancer-related survival in rectal cancer". [PDF]

Ann Med
Wang B, Huang J, Chen Z.
europepmc   +1 more source

A new perspective on radiotherapy in the comprehensive treatment of cancer

Precision Radiation Oncology, EarlyView.
Radiotherapy remains a key component in the comprehensive management of cancer. Its effectiveness is significantly improved through strategic combinations with chemotherapy, targeted therapy, and immunotherapy, providing a range of therapeutic outcomes from cure to palliative care.
Yingze Ma, Hongxuan Yu, Shijie Shang, Shixin Shan, Dawei Chen   +4 more
wiley   +1 more source

Radical prostatectomy after rectal cancer surgery: surgical challenges and technical strategies - a case series. [PDF]

Int J Surg Case Rep
Imasato N, Nakanishi Y, Hirose K, Kataoka M, Yajima S, Masuda H.   +5 more
europepmc   +1 more source

Temporal Patterns and Resolution of Toxicities Following Hypofractionated Salvage Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy

The Prostate, EarlyView.
ABSTRACT Background Hypofractionated salvage radiotherapy is increasingly used for biochemical recurrence of prostate cancer post‐prostatectomy, yet its toxicity profile remains underexplored. This study evaluates the incidence, timing, and resolution of treatment‐related toxicities in this setting.
Bum‐Sup Jang, Seok‐Joo Chun, Jin Ho Kim   +2 more
wiley   +1 more source

Development of a nomogram for predicting anastomotic leakage after rectal cancer surgery incorporating inflammatory indices. [PDF]

Front Oncol
Zhao F, Zheng D, Zhang W, Liu Y, Wang T.
europepmc   +1 more source

Real‐World Clinical Evaluation of S2,3PSA Test in a Prostate Biopsy Cohort With PSA Level of 4–10 ng/mL

The Prostate, EarlyView.
ABSTRACT Background Prostate‐specific antigen (PSA) is a widely used prostate cancer marker; however, its use is limited by its low specificity. Novel biomarkers are being explored to avoid unnecessary biopsies. A new prostate cancer marker, S2,3PSA, became eligible for insurance coverage in February 2024.
Jun Furumido, Sho Nonoyama, Chika Hoshi (Hosokawa), Shogo Aizawa, Nariaki Ozaki, Takuto Morita, Akihiro Yamashita, Issei Tsunemi, Ryo Kato, Kanta Hori, Naohiko Shimoda   +10 more
wiley   +1 more source

Patterns of recurrence and outcomes of poor responders to neoadjuvant long-course chemoradiotherapy for rectal cancer. [PDF]

J Gastrointest Oncol
Yang Y, Luo D, Ding W, Li Q, Li X.
europepmc   +1 more source

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

Phytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee, Yu Jin So, Il‐Joo Jo, Ji Yong Jang, Tae Han Yook, Jun Ho Lee, Sung Wook Kim, Kangwook Lee, Soo Jung Park, Gabsik Yang   +9 more
wiley   +1 more source